Figure 1 .

Study design. Patients with be randomized in a 1:2 ratio between Arm 1 (Standard of care) vs. Arm 2 (SABR).

Palma et al. BMC Cancer 2012 12:305   doi:10.1186/1471-2407-12-305
Download authors' original image